Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
Latest Information Update: 05 Oct 2021
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Rituximab
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 06 Aug 2021 Status changed from active, no longer recruiting to completed.
- 10 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 18 May 2018 Status changed from active, no longer recruiting to recruiting.